🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these accounts privately for supplier links, while also obtaining promotional offers.

Active Commerce on Social Networks

Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and assertions of rapid UK delivery. Sellers market the drug there before directing customers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals administering substances of uncertain source.

Some experts said the popularity for the experimental drug could be connected to the increasing price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, advertising, and consumer regulations, risking penalties, legal action or prison.

Service Reaction and Content Removal

According to the social media company, the platform has taken down problematic content and prohibited related hashtags and search suggestions. The organization said it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.

Digital Trading Activities

Investigations also discovered communities with up to nine thousand participants selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at residence.

Within minutes of entering one group, a seller shared WhatsApp details, where most purchases occur. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, health issues or past usage.

Item Details and Pricing

Inside these communities, messages show dark colored parcels with Royal Mail labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When questioned how long a injector should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram stated it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her team has already encountered individuals injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to potentially serious medical dangers”.